Table 2.
Variable | No CAV (n = 66) |
CAV (n = 15) |
p-value |
---|---|---|---|
Change in mean MIT (mm) |
0.03 ± 0.01 | 0.17 ± 0.04 | <0.001 |
Male sex | 74% | 93% | 0.17 |
White race | 74% | 80% | 0.75 |
Diabetes | 32% | 40% | 0.56 |
BMI | 27.6 ± 1.3 | 25.6 ± 0.6 | 0.18 |
Rejection | 14% | 7% | 0.74 |
Total cholesterol (mg/dl) |
138 ± 12.7 | 139 ± 5.2 | 0.95 |
HDL (mg/dl) | 49 ± 2.8 | 39 ± 2.9 | 0.1 |
LDL (mg/dl) | 76 ± 3.8 | 83 ± 9.4 | 0.48 |
Triglyceride (mg/dl) | 77 ± 4.2 | 85 ± 11.7 | 0.51 |
BMI, body mass index; CAV, cardiac allograft vasculopathy; CTOT05, Clinical Trials in Organ Transplantation 05; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MIT, maximal intimal thickness.